Literature DB >> 11581046

Changes in visual acuity in a population over a 10-year period : The Beaver Dam Eye Study.

R Klein1, B E Klein, K E Lee, K J Cruickshanks, R J Chappell.   

Abstract

PURPOSE: To describe the change in visual acuity in a 10-year period.
DESIGN: Population-based cohort study. PARTICIPANTS: Included 3684 persons 43 to 86 years of age at the time of a baseline examination in 1988 to 1990, living in Beaver Dam, Wisconsin, at a follow-up examination in 1993 to 1995 and/or 1998 to 2000.
METHODS: Best-corrected visual acuity was measured, after refraction, with logarithm of the minimum angle of resolution charts using a modification of the Early Treatment Diabetic Retinopathy Study protocol. MAIN OUTCOMES MEASURES: Doubling of the visual angle and incidence of visual impairment.
RESULTS: The change in the mean number of letters read correctly over the 10-year period varied in the right eye from -0.9 (standard deviation [SD] = 5.5) and in the left eye from -1.2 (SD = 6.6) in people between 43 and 54 years of age to -11.0 (SD = 20.0) in the right eye and -12.6 (SD = 20.4) in the left eye in people 75 years of age or older (n = 184) at baseline. Over the 10-year period, 5.9% of the population had impaired vision (20/40 or worse in the better eye) develop, 0.8% had severe visual impairment (20/200 or worse in the better eye) develop, 4.8% had doubling of the visual angle, and 3.9% had improved vision. People who were 75 years of age or older at baseline were 15.0 times (95% confidence interval [CI], 10.9-20.6; P < 0.001) as likely to have impaired vision develop, 9.3 times (95% CI, 6.5-13.3; P < 0.001) as likely to have doubling of the visual angle, and 19.8 times as likely (95% CI, 8.4-46.4; P < or = 0.001) to have severe visual impairment develop than people younger than 75 years of age at baseline. For the 82 persons 75 years of age or older, currently residing in a nursing or group home at follow-up, they were 2.6 times (95% CI, 1.45-4.52) as likely to have impaired vision develop, 1.6 times (95% CI, 0.47-5.62) as likely to have severely impaired vision develop, and 3.6 times (95% CI, 1.96-6.78) as likely to have had a doubling of the visual angle than those not residing in a nursing or group home at follow-up.
CONCLUSIONS: These data provide precise population-based estimates of the 10-year incidence of loss of vision over a wide spectrum of ages and show that decreased visual acuity in people 75 years of age after 10 years is a common finding, especially in those who are admitted to nursing or group homes.

Entities:  

Mesh:

Year:  2001        PMID: 11581046     DOI: 10.1016/s0161-6420(01)00769-2

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  65 in total

1.  A whole-genome screen of a quantitative trait of age-related maculopathy in sibships from the Beaver Dam Eye Study.

Authors:  James H Schick; Sudha K Iyengar; Barbara E Klein; Ronald Klein; Karlie Reading; Rachel Liptak; Christopher Millard; Kristine E Lee; Sandra C Tomany; Emily L Moore; Bonnie A Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-04-24       Impact factor: 11.025

2.  Dissection of genomewide-scan data in extended families reveals a major locus and oligogenic susceptibility for age-related macular degeneration.

Authors:  Sudha K Iyengar; Danhong Song; Barbara E K Klein; Ronald Klein; James H Schick; Jennifer Humphrey; Christopher Millard; Rachel Liptak; Karlie Russo; Gyungah Jun; Kristine E Lee; Bonnie Fijal; Robert C Elston
Journal:  Am J Hum Genet       Date:  2003-12-19       Impact factor: 11.025

3.  Health-related quality of life before and after a breast cancer diagnosis.

Authors:  Amy Trentham-Dietz; Brian L Sprague; Ronald Klein; Barbara E K Klein; Karen J Cruickshanks; Dennis G Fryback; John M Hampton
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

4.  Assessing responses of the macula in patients with macular holes using a new system measuring localized visual acuity and the mfERG.

Authors:  Janet P Szlyk; Thasarat S Vajaranant; Rimki Rana; Wico W Lai; Jose S Pulido; Jennifer Paliga; Norman P Blair; William Seiple
Journal:  Doc Ophthalmol       Date:  2005 Mar-May       Impact factor: 2.379

5.  Misclassification can explain most apparent regression of age-related macular degeneration: results from multistate models with misclassification.

Authors:  Ronald E Gangnon; Kristine E Lee; Barbara E K Klein; Sudha K Iyengar; Theru A Sivakumaran; Ronald Klein
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

6.  Statin use and the five-year incidence and progression of age-related macular degeneration.

Authors:  Ronald Klein; Michael D Knudtson; Barbara E K Klein
Journal:  Am J Ophthalmol       Date:  2007-05-02       Impact factor: 5.258

7.  The relationship of retinopathy in persons without diabetes to the 15-year incidence of diabetes and hypertension: Beaver Dam Eye Study.

Authors:  Ronald Klein; Barbara E K Klein; Scot E Moss; Tien Y Wong
Journal:  Trans Am Ophthalmol Soc       Date:  2006

Review 8.  Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

Authors:  J A P Da Silva; J W G Jacobs; J R Kirwan; M Boers; K G Saag; L B S Inês; E J P de Koning; F Buttgereit; M Cutolo; H Capell; R Rau; J W J Bijlsma
Journal:  Ann Rheum Dis       Date:  2005-08-17       Impact factor: 19.103

9.  Risk alleles in CFH and ARMS2 and the long-term natural history of age-related macular degeneration: the Beaver Dam Eye Study.

Authors:  Ronald Klein; Chelsea E Myers; Stacy M Meuer; Ronald E Gangnon; Theru A Sivakumaran; Sudha K Iyengar; Kristine E Lee; Barbara E K Klein
Journal:  JAMA Ophthalmol       Date:  2013-03       Impact factor: 7.389

10.  Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.

Authors:  Ronald Klein; Stacy M Meuer; Chelsea E Myers; Gabriëlle H S Buitendijk; Elena Rochtchina; Farzana Choudhury; Paulus T V M de Jong; Roberta McKean-Cowdin; Sudha K Iyengar; Xiaoyi Gao; Kristine E Lee; Johannes R Vingerling; Paul Mitchell; Caroline C W Klaver; Jie Jin Wang; Barbara E K Klein
Journal:  Ophthalmic Epidemiol       Date:  2014-02       Impact factor: 1.648

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.